DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsLowNeutral
Announced Mon, 28 Jul · 12:58 IST

Divi's Laboratories Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Divi's Laboratories has informed the exchanges that it will release its unaudited financial results for the quarter ended June 30, 2025 (Q1FY26) on August 6, 2025. On the same day, at 1:30 PM IST, the company's management will host an earnings conference call to discuss the financial performance. Investors can join via DiamondPass pre-registration or by dialing the provided numbers. A transcript of the call will be uploaded to the company's website (www.divislabs.com). The disclosure has been made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements, 2015.

Likely market impact

This is a routine advance notice giving investors clarity on the timeline for Q1FY26 results and an opportunity to hear directly from management. The actual stock reaction will depend on the numbers and commentary shared on August 6, not on this scheduling announcement.